Lattawin Ovules: the effective medical device against irritation and intimate burning
Dryness, burning, itching, irritation, and discomfort during intercourse are common but often overlooked symptoms that affect many women at all stages of life. Whether due to hormonal changes, menopause, stress, antibiotic use, or imbalances in the vaginal microbiota, these disturbances can compromise quality of life, intimacy, and overall psychophysical well-being.
It is in this context that Lattawin Ovules is positioned as a vaginal medical device indicated for the treatment and prevention of vaginal affections, including those of mycotic origin.
Gruppo FarmaImpresa conducted an observational clinical study on Lattawin, and we are pleased to announce that the results confirm its effectiveness in improving the symptoms of vaginal dryness and vulvovaginal alterations, restoring comfort and intimate well-being to patients.
A Clinical Study Supporting the Efficacy of Lattawin Ovules
The efficacy of Lattawin Ovules (FT.CE.23) was evaluated through an observational clinical investigation based on the Vulvovaginal Symptoms Questionnaire (VSQ), a validated tool for measuring symptoms, emotional impact, and sexual impact in women with vulvovaginal disorders. Twenty patients were treated for 4 weeks, and the results were surprising.
The graph shows that:
- The mean score of the VSQ questionnaire (16-item scale) significantly decreased, going from 4.90 to 0.40 after 4 weeks of treatment (p < 0.001) , with an average reduction of 4.5 points.
- 60% of patients achieved complete symptom remission, registering a score of zero.
- Furthermore, 90% of participants no longer presented symptoms such as irritation, dryness, itching, or burning at the end of the study.
- Aspects related to emotional impact and sexual life also showed a clinically and statistically significant improvement.
No adverse events were registered during the study, confirming the excellent safety profile of Lattawin. The treatment was well tolerated by all patients.
Who is Lattawin Ovules indicated for?
The device is indicated for:
- Recurrent vaginal infections of fungal and/or bacterial origin
- Prevention and/or treatment of chronic candidiasis
- Disorders from vaginal microbiota alterations
- Recurrent discomforts such as itching, burning, and discharge
- Post-antifungal treatment support
Why choose Lattawin Ovules?
- Clinically tested: Efficacy demonstrated on multiple parameters (symptoms, emotions, sexual impact).
- Safe: No side effects detected in the study.
- Multifunctional: Comprehensive treatment of vulvovaginal disorders.
- Suitable for all ages: Also for fertile age, menopause, and perimenopause.
Looking for a professional line ready for distribution or private label?
We are manufacturers of medical devices, food supplements, and cosmetics. Lattawin Ovules is available for your business as a ready-to-market line or in private label.
